Year |
Citation |
Score |
2019 |
Robinson MH, Maximov V, Lallani S, Farooq H, Taylor MD, Read RD, Kenney AM. Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma. Scientific Reports. 9: 13611. PMID 31541170 DOI: 10.1038/s41598-019-50088-1 |
0.352 |
|
2019 |
Chen AS, Read RD. Drosophila melanogaster as a Model System for Human Glioblastomas. Advances in Experimental Medicine and Biology. 1167: 207-224. PMID 31520357 DOI: 10.1007/978-3-030-23629-8_12 |
0.428 |
|
2018 |
Chen AS, Wardwell-Ozgo J, Shah NN, Wright D, Appin CL, Vigneswaran K, Brat DJ, Kornblum HI, Read RD. Drak/STK17A drives neoplastic glial proliferation through modulation of MRLC signaling. Cancer Research. PMID 30530503 DOI: 10.1158/0008-5472.Can-18-0482 |
0.498 |
|
2018 |
Read RD. Pvr receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells in . Development (Cambridge, England). PMID 30327326 DOI: 10.1242/dev.164285 |
0.359 |
|
2018 |
Mukherjee S, Tucker-Burden C, Kaissi E, Newsam A, Duggireddy H, Chau M, Zhang C, Diwedi B, Rupji M, Seby S, Kowalski J, Kong J, Read R, Brat DJ. CDK5 Inhibition Resolves PKA/cAMP-Independent Activation of CREB1 Signaling in Glioma Stem Cells. Cell Reports. 23: 1651-1664. PMID 29742423 DOI: 10.1016/J.Celrep.2018.04.016 |
0.313 |
|
2017 |
Mukherjee S, Tucker-Burden C, Zhang C, Kong J, Chau M, Read R, Brat DJ. Abstract 3897: Novel inhibitor of GBM stem cells targets unique CREB & Myc-mediated self-renewal pathways regulated by CDK5 Cancer Research. 77: 3897-3897. DOI: 10.1158/1538-7445.Am2017-3897 |
0.377 |
|
2013 |
Read RD, Fenton TR, Gomez GG, Wykosky J, Vandenberg SR, Babic I, Iwanami A, Yang H, Cavenee WK, Mischel PS, Furnari FB, Thomas JB. A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma. Plos Genetics. 9: e1003253. PMID 23459592 DOI: 10.1371/Journal.Pgen.1003253 |
0.642 |
|
2013 |
Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Read R, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/Neuonc/Not174 |
0.51 |
|
2009 |
Read RD, Cavenee WK, Furnari FB, Thomas JB. A drosophila model for EGFR-Ras and PI3K-dependent human glioma. Plos Genetics. 5: e1000374. PMID 19214224 DOI: 10.1371/journal.pgen.1000374 |
0.54 |
|
2007 |
Vidal M, Warner S, Read R, Cagan RL. Differing Src signaling levels have distinct outcomes in Drosophila. Cancer Research. 67: 10278-85. PMID 17974969 DOI: 10.1158/0008-5472.Can-07-1376 |
0.637 |
|
2005 |
Read RD, Goodfellow PJ, Mardis ER, Novak N, Armstrong JR, Cagan RL. A Drosophila model of multiple endocrine neoplasia type 2. Genetics. 171: 1057-81. PMID 15965261 DOI: 10.1534/Genetics.104.038018 |
0.616 |
|
2004 |
Read RD, Bach EA, Cagan RL. Drosophila C-terminal Src kinase negatively regulates organ growth and cell proliferation through inhibition of the Src, Jun N-terminal kinase, and STAT pathways. Molecular and Cellular Biology. 24: 6676-89. PMID 15254235 DOI: 10.1128/MCB.24.15.6676-6689.2004 |
0.63 |
|
2000 |
Miller DT, Read R, Rusconi J, Cagan RL. The Drosophila primo locus encodes two low-molecular-weight tyrosine phosphatases. Gene. 243: 1-9. PMID 10675607 DOI: 10.1016/S0378-1119(99)00553-3 |
0.555 |
|
Show low-probability matches. |